Ventas
VTR
Market cap $26.7B

63.60 USD

+0.10

0.16%

At close Nov 15, 4:00 PM EST

After hours

63.60

+0.00

0.00%

1 day

0.16%

5 days

-2.08%

1 month

-1.07%

3 months

9.58%

6 months

30.57%

Year to date

25.77%

1 year

43.05%

5 years

9.09%

10 years

-7.56%

About: Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Employees: 486

Financials Real Estate Investment Trusts

0

Funds holding %

of 6,704 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

50% more funds holding in top 10

Funds holding in top 10: 10 [Q2] → 15 (+5) [Q3]

28% more call options, than puts

Call options by funds: $58.7M | Put options by funds: $46M

26% more capital invested

Capital invested by funds: $20B [Q2] → $25.2B (+$5.16B) [Q3]

26% more repeat investments, than reductions

Existing positions increased: 280 | Existing positions reduced: 223

15% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 82

2% more funds holding

Funds holding: 685 [Q2] → 697 (+12) [Q3]

1.92% less ownership

Funds ownership: 96.68% [Q2] → 94.76% (-1.92%) [Q3]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$64

1%

upside

Avg. target

$68

7%

upside

High target

$71

12%

upside

5 analyst ratings

4 positive

80%

1 neutral

20%

0 negative

0%

Scotiabank Nicholas Yulico 56% 1-year accuracy 18 / 32 met price target	2%upside $65	Sector Perform Maintained	11 Oct 2024
Wells Fargo John Kilichowski 100% 1-year accuracy 4 / 4 met price target	12%upside $71	Overweight Assumed	1 Oct 2024
Evercore ISI Group Steve Sakwa 53% 1-year accuracy 31 / 59 met price target	10%upside $70	Outperform Maintained	16 Sept 2024
Wedbush Richard Anderson 69% 1-year accuracy 18 / 26 met price target	12%upside $71	Outperform Maintained	10 Sept 2024
Evercore ISI Group Steve Sakwa 53% 1-year accuracy 31 / 59 met price target	1%upside $64	Outperform Maintained	28 Aug 2024

See Analyst Rankings

Financial journalist opinion

Based on 16 articles about VTR published over the past 30 days

Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that management will participate in investor meetings at Nareit's REITworld 2024 Annual Conference (the “Nareit Conference”) on November 18-19, 2024. Any new or updated written materials that the Company expects to use in connection with its participation at the Nareit Conference will be made available on the Company's website on or prior to the morning of November 18, 2024. Any such materials will be.

Ventas to Participate in Investor Meetings at Nareit's REITworld 2024 Annual Conference

Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it priced an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below for gross proceeds of approximately $677 million before underwriting discounts and estimated offering expenses payable by the Company. The shares will be offered from time to time in one or more transactions on the New York Stock Exchange, in the over-th.

Ventas Announces Pricing of an Underwritten Offering of 10.6 Million Shares of Common Stock

Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) announced today that it is commencing an underwritten public offering of 10,600,000 shares of its common stock in connection with the forward sale agreement described below. Ventas intends to grant the underwriter a 30-day option to purchase up to an additional 1,590,000 shares of its common stock. If such option is exercised, then Ventas plans to enter into an additional forward sale agreement with the forward purch.

Ventas Announces Underwritten Offering of 10.6 Million Shares of Common Stock

Zacks Investment Research

Here's Why Ventas Stock is an Apt Portfolio Pick for Now

Rising senior citizens' population and favorable outpatient visit trends are likely to benefit VTR.

Here's Why Ventas Stock is an Apt Portfolio Pick for Now

Ventas: Growth Set To Continue In The Years Ahead

Ventas is a healthcare REIT focused on senior housing, outpatient medical & research, and triple-net lease properties. The Q3 2024 results were solid and the company increased its normalized FFO midpoint outlook. With a valuation above private market alternatives and distressed peers, Ventas is tapping debt and equity markets to grow its portfolio and increase normalized FFO.

Ventas: Growth Set To Continue In The Years Ahead

MOBs, Office But No Need For Life Support

Unlike in traditional office, healthcare requires in-office interactions, which reduces the risk of ‘work from home'. Outpatient services are taking market share from inpatient (hospital) settings due to better costs and, in some cases, outcomes. America's rapidly aging population is a tailwind for all healthcare real estate.

MOBs, Office But No Need For Life Support

Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript

Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript

Ventas, Inc. (VTR) Q3 2024 Earnings Call Transcript

Zacks Investment Research

Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised

VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.

Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised

Zacks Investment Research

Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings

Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings

Zacks Investment Research

Ventas (VTR) Q3 FFO Match Estimates

Ventas (VTR) came out with quarterly funds from operations (FFO) of $0.80 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.75 per share a year ago.

Ventas (VTR) Q3 FFO Match Estimates

See News Rankings

Charts implemented using Lightweight Charts™